Navigation Links
BioNeutral's Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
Date:7/13/2009

omings by being ineffective, cumbersome to use or require very lengthy periods of time to be effective at all in eliminating health threatening spores.

A room temperature, cold, sporicide/sterilant with the rapid kill demonstrated by Ygiene(TM) Hospital Grade will provide a huge economic advantage for future users. By delivering a safe easy to use and a much quicker turn around time for total sterilization of equipment and facilities, BioNeutrals Ygiene(TM) will greatly reduce the waste of human resources and capital currently experienced in health care facilities and will maximize value to the user & increased safety for the patients.

Dr. Andy Kielbania PhD, Chief Scientist at BioNeutral Group stated: "These independent lab validation results from ATS show that we have developed what we believe is the best, and I emphasize the best, antimicrobial coming to the market. By using the strategy of raising the bar for antimicrobial performance, we believe our superior Ygiene(TM) Hospital Grade antimicrobial will provide much cleaner, safer and healthier environments in health care facilities globally. Reducing the loss of lives and wasteful expenditures of human resources and money by diminishing Hospital Acquired Infections (ACI) is our goal. These independent test results stand by themselves and are consistent with our achieving our goals and objectives. These results are incredible and validate all of our efforts."

Dr. Philip M. Tierno Jr. MS, PhD Chairman of BioNeutral Group Scientific Advisory Board stated: "The sporocidal data on Ygiene(TM)'s performance that I reviewed is quite impressive. Two immediate and important applications of Ygiene(TM) come to mind:

1- Perhaps the biggest challenge facing hospitals worldwide is eradication of Clostridium difficile spores in the environment in a timely fashion thereby reducing or eliminating possible nosocomial spread. Ygiene(TM) safely and e
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
2. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
3. Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.
4. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
5. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
6. Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
7. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
8. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
9. University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
10. New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More
11. TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... These bearings are uniquely suited to prevent loss of ... of the high temperatures . , Recently, a ... design engineers at Graphite Metallizing to overcome problems with ... manufacturing operation, pans containing blocks of powder mixture are ...
(Date:7/31/2014)... 2014 CollabRx, Inc. (NASDAQ: CLRX), a ... in oncology, today announced that it will hold an ... the Company's financial results for the first quarter of ... business in the current fiscal year. , The dial-in ... August 14, 2014, at 5 p.m. EDT (2 p.m. ...
(Date:7/31/2014)... Francisco, Calif. (PRWEB) July 31, 2014 ... newly diagnosed patients with an overview of the disease ... management of drug side effects, as well as updates ... “We’re grateful to Dr. Sandy Srinivas for organizing this ... survivor of kidney cancer. “Sandy and her colleagues have ...
(Date:7/31/2014)... “Rapid technological advances will spread ... increasing unemployment, depressing American consumer spending and further ... Catch 22—we need automated manufacturing if we are ... says economist and corporate relocation expert Dr. Ron ... Pro-Business States for 2014, co-published with the American ...
Breaking Biology Technology:Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4
... , ... /PRNewswire-Asia-FirstCall/ --,China Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN; ... and,retailer of pharmaceuticals in Northeastern China, today announced it ... Drug List. , The Chinese ...
... , SEATTLE, Nov. 30 ... announced today that its new class of platinum-based anti-tumor ... activity compared to currently available platinum-based compounds as well ... lines. The results were presented in a paper ...
... ... Elsevier, the world,s,leading publisher of scientific, medical and technical products and services,today ... million indexed records from more than 7,000,active, peer reviewed journals. , ... new biomedical,and pharmaceutical insights. Now, new developments and updates include: , , ...
Cached Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3
(Date:7/31/2014)... lurks beneath many of the roughly 156,000 gas ... is corrosion in parts of underground gas storage ... contamination of groundwater, a source of drinking water. ... have reported many rapidly corroding gas storage tank ... generally associated with use of gasoline-ethanol blends and ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
(Date:7/31/2014)... been made to help better identify and treat those with ... and enlarging of medium sized arteries in the body, which ... causing damage. In a new report appearing in August 2014 ... provide evidence that that FMD may not be limited to ... connection to abnormalities of bones and joints, as well as ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2C. difficile vaccine proves safe, 100 percent effective in animal models 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... 25-year non-stop research expeditioninto the deep ocean. Over the ... are completing the installation off the British Columbia coast of ... observatory. Using three ships and at least one ROV, ... 400 instruments and sensors to the seafloor where they are ...
... Van Andel Research Institute (VARI) investigators ... therapeutic target in the treatment of the most aggressive ... have few treatment options. "Breast cancer mortality rates ... to traditional treatments tend to be more aggressive and ...
... For the first time, an international group of researchers ... of DNA on chromosome 6. This is the ... The LSUHSC research team was led by Nancy Buccola, APRN, ... Sciences Center New Orleans, who also coordinated the ten clinical ...
Cached Biology News:World's largest ocean observatory takes shape 2World's largest ocean observatory takes shape 3Possible drug target found for one of the most aggressive breast cancers 2LSUHSC research helps link schizophrenia to specific DNA region 2
...
Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
... Bio-Beads SM-2 adsorbents are macroporous polystyrene beads ... high surface area for adsorbing organics of ... solutions. The beads are useful for the ... agents; for example, the removal of detergents ...
... Anti-Mi-2 Immunogen : Fusion ... residues 474-970 of human Mi-2 ... 0.105M NaCl, 0.035% sodium azide, ... routinely evaluated by immunoblot on ...
Biology Products: